Within the clinical spectrum of MS, emphasis is on variations, factors influencing the clinical course, and differential diagnosis and treatment, with a highlight on selection of appropriate patients ...for "experimental" therapies.
A 32-year-old obese woman with hypertension and a three-year history of pseudotumor cerebri developed bilateral juxtapapillary subretinal neovascular membranes. To our knowledge, this is the first ...reported case of bilateral subretinal neovascular membranes complicating the course of this disease. The subretinal neovascular membrane in the left eye spontaneously involuted, but because the membrane in the right eye threatened the foveola, the patient underwent argon-laser photocoagulation. The subretinal fluid and hemorrhage progressively resolved, the membrane was replaced by fibrous tissue, and visual acuity improved. The pathogenesis of the subretinal neovascular membranes was presumably secondary to pressure deformity of the border of Bruch's membrane at the optic disk, creating a discontinuity of normal anatomic apposition of the chorioretinal layers. This anatomic dehiscence, coupled with hypoxia created by axonal tissue swelling and resultant impaired vascular perfusion of the tissues, led to the development of subretinal neovascular membranes.
Sera from patients with multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), subacute sclerosing panencephalitis (SSPE), and myasthenia gravis (MG) were assayed for immune complexes. Three ...techniques were used: a modified Raji cell assay, the 125I-Clq polyethyleneglycol assay, and a solid-phase clq assay. Immune complex levels were elevated in sera of some patients with MS, ALS, and SSPE, but the elevations were modest when compared with active systemic lupus erythematosus (SLE). In some cases, abnormalities were detected in only one assay system; in other cases, abnormalities were detected by two or three assay systems. In MS, immune complex elevations correlated with active disease and with decreased suppressor cell activity. Of two ALS patients with antecedent poliomyelitis, one had markedly increased levels of immune complexes in two assays. In MG, levels of immune complexes did not differ from those of controls.
Thalidomide and lymphocyte function Aronson, I K; Weber, L; West, D ...
Journal of the American Academy of Dermatology,
02/1986, Volume:
14, Issue:
2 Pt 1
Journal Article
In vitro immune function was assessed in patients with multiple sclerosis (MS) who were receiving Imuran therapy, in untreated MS patients, and in controls. In untreated stable MS patients, ...concanavalin A (Con A)-driven mitogenic reactivity (T effector function) and Con A-induced suppressor activity were modestly reduced compared to controls; pokeweed mitogen-induced immunoglobulin G (IgG) secretion was increased. Untreated patients with active MS demonstrated high levels of IgG secretion and marked decreases in suppressor activity. In Imuran-treated patients, Con A mitogenic responses and suppressor activity were comparable to those observed in untreated stable patients, and IgG secretion was reduced. The results in the treated patients likely reflect a direct effect of Imuran on B cell function rather than an indirect effect mediated via suppressor cells.
In vitro modulation of human T lymphocyte surface differentiation antigens T3, T8, and T4, by their respective monoclonal antibodies, was studied as a function of donor age. Kinetic studies performed ...on lymphocytes from young adults indicated that modulation is dependent on concentration of antibody used and duration of culture. OKT3 modulates T3 rapidly (maximum at less than 24 hr) and relatively completely (79% at the highest concentration of antibody used). By 48 hr, regeneration of the T3 antigen is apparent. T8 modulation by OKT8 is slower (continued modulation at 48 hr) and less complete than is T3 modulation by OKT3. OKT4 does not modulate the T4 antigen. In elderly individuals modulation of T3 by OKT3 is preserved whereas modulation of T8 by OKT8 is significantly reduced (24 +/- 8% at 48 hr vs 53 +/- 4% for young controls). These observations document further age-related changes in properties of human T suppressor cells.
PDF
